Magazine

This is the first in a series of quarterly publications for the Global Health Council looking at drug development, healthcare providers such as hospitals and digital health, payments and patient wellness. This first article looks at the implications of the disease treatments coming out of advanced research and artificial intelligence and the broader shift to digitalisation in healthcare. The next issue will focus on the providers of healthcare.

Monthly analysis: February

Where do you begin to summarise a year that has been the most challenging on a global scale in living memory?

Comment from Bedy Yang, managing partner and head of ecosystems, 500vc, and Ee-Ling Lim, regional director for Asia-Pacific

Comment from Carol Strobel, operating partner, Redpoint eVentures, Brazil

Comment from Vanessa Colella, chief innovation officer, Citi, and David Kidder, co-founder and CEO, Bionic

Comment from Amy Burr, managing director, JetBlue Technology Ventures

Feature: artificial intelligence driving disease prevention, digital health enables personalised medicine, investment takes off